[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351788-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351788-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","yy1-mediated-ndufa9-upregulation-promotes-nsclc-cell-growth-through-mitochondrial-and-akt-mtor-pathway-modulation","YY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation","","NSCLC drives substantial morbidity and mortality, yet the expression programs and functional contribution of NDUFA9 in tumor development remain unclear. This study uses TCGA and single-cell RNA data to show NDUFA9 upregulation in NSCLC tissues and proliferating malignant populations, linked with advanced pathology and worse survival. Functional assays demonstrate that NDUFA9 depletion disrupts mitochondrial activity, lowers ATP, increases ROS, and suppresses proliferation and migration while inducing apoptosis. Mechanistically, YY1 directly activates NDUFA9 and enhances Akt-mTOR signaling, confirmed in xenografts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/yy1-mediated-ndufa9-upregulation-promotes-nsclc-cell-growth-through-mitochondrial-and-akt-mtor-pathway-modulation/351788/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/yy1-mediated-ndufa9-upregulation-promotes-nsclc-cell-growth-through-mitochondrial-and-akt-mtor-pathway-modulation/351788.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study identify as the key role of NDUFA9 in NSCLC?","Question",{"text":63,"@type":64},"NDUFA9 upregulation supports NSCLC cell growth by regulating mitochondrial metabolism and promoting malignant phenotypes, including proliferation and migration.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NDUFA9 depletion affect mitochondria and cellular energy in NSCLC cells?",{"text":68,"@type":64},"NDUFA9 shRNA or knockout compromises mitochondrial function, reflected by reduced oxygen consumption, complex I activity, ATP production, and mtDNA content, alongside mitochondrial depolarization and increased ROS.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism connects YY1 to NDUFA9 and downstream signaling?",{"text":72,"@type":64},"Bioinformatics and experiments show YY1 directly binds to and upregulates NDUFA9. NDUFA9 then activates the Akt-mTOR pathway by promoting mTOR kinase activity and phosphorylation of Akt and S6K.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351788,1790175806,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nYY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation  \nYubo Yan1,3, Yuge Zhao2,3, Jun Tang2,3, Xiwen Wang2, Jungang Zhao2 ✉ and Yingnan Yang 1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | NSCLC remains a primary contributor to cancer-related mortality. This study comprehensively elucidates the expression and the functional role of NDUFA9 in NSCLC pathogenesis. Our initial bioinformatic analyses, drawing from TCGA and single-cell RNA sequencing data, revealed a signiﬁcant upregulation of NDUFA9 expression within NSCLC tumor tissues and cancer cell populations, correlating with unfavorable clinicopathological indicators, including advanced pathological T stage, male gender, smoking history, and diminished overall survival. Furthermore, NDUFA9 was distinctly enriched in proliferating cancer cells and malignant epithelial cells across diverse metastatic sites. Experimental validation conﬁrmed NDUFA9’s heightened mRNA and protein expression in both locally-treated NSCLC patient tissues and various NSCLC cell types. Functionally, NDUFA9 shRNA or knockout compromised mitochondrial function in NSCLC cells. This impairment was evidenced by a reduced oxygen consumption rate, diminished mitochondrial complex I activity, decreased ATP production, mitochondrial depolarization, reduced mtDNA contents, and an augmented generation of ROS. Concomitantly, NDUFA9 depletion signiﬁcantly suppressed key malignant phenotypes, including cell proliferation and migration, while inducing apoptosis in NSCLC cells. Conversely, NDUFA9 overexpression in NSCLC cells enhanced mitochondrial function and promoted malignant cellular phenotypes. NDUFA9 was identiﬁed as a positive regulator of the Akt-mTOR signaling pathway; its depletion inhibited, and its overexpression enhanced, mTOR kinase activity and the phosphorylation of Akt and S6K in primary NSCLC cells. Bioinformatics predictions, subsequently validated experimentally, established YY1 as a pivotal transcription factor directly binding to and upregulating NDUFA9 expression in NSCLC tissues and cells. Finally, in vivo xenograft studies demonstrated that NDUFA9 silencing suppressed tumor growth, corroborating the in vitro ﬁndings by inhibiting mitochondrial function, proliferation, Akt-mTOR activation, and inducing apoptosis within tumor tissues. Thus, NDUFA9 is a crucial regulator of mitochondrial metabolism and malignant progression in NSCLC, driven by YY1-mediated |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| transcriptional control. |  |  |\n|  | Cell Death and Disease (2026)17:526; [https://doi.org/10.1038/s41419-026-08562-y](https://doi.org/10.1038/s41419-026-08562-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nNon-small cell lung carcinoma (NSCLC) represents a signiﬁcant global health burden characterized by substantial morbidity and mortality [1, 2] . exhibiting a complex epidemiology with increasing incidence rates inﬂuenced by environmental and genetic factors [2, 3] . Despite advancements in therapeutic modalities encompassing surgical resection, radiation therapy, chemotherapy, targeted therapies, and immunotherapies [4, 5] . NSCLC remains a leading cause of cancer-related deaths worldwide [6, 7] . The classiﬁcation of NSCLC primarily distinguishes between adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [1, 2] .  \nCurrently, targeted therapy for NSCLC is a cornerstone of treatment for patients harboring speciﬁc oncogenic driver mutations [2, 3, 8] . Approved targets include EGFR, ALK, ROS1, BRAF (speciﬁcally V600E), MET (exon 14 skipping and  \nampliﬁcation), RET fusions, NTRK fusions, and KRAS G12C, with corresponding tyrosine kinase inhibitors (TKIs) demonstrating signiﬁcant improvements in pr","cbCaisP23IipAPCQ","https://ap.wps.com/l/cbCaisP23IipAPCQ","pdf",6798666,"English","# Introduction\n## Rationale and current NSCLC therapies\n## Resistance and unmet clinical needs\n## Mitochondrial involvement in NSCLC","[{\"question\":\"What does the study identify as the key role of NDUFA9 in NSCLC?\",\"answer\":\"NDUFA9 upregulation supports NSCLC cell growth by regulating mitochondrial metabolism and promoting malignant phenotypes, including proliferation and migration.\"},{\"question\":\"How does NDUFA9 depletion affect mitochondria and cellular energy in NSCLC cells?\",\"answer\":\"NDUFA9 shRNA or knockout compromises mitochondrial function, reflected by reduced oxygen consumption, complex I activity, ATP production, and mtDNA content, alongside mitochondrial depolarization and increased ROS.\"},{\"question\":\"What mechanism connects YY1 to NDUFA9 and downstream signaling?\",\"answer\":\"Bioinformatics and experiments show YY1 directly binds to and upregulates NDUFA9. NDUFA9 then activates the Akt-mTOR pathway by promoting mTOR kinase activity and phosphorylation of Akt and S6K.\"}]","YY1-mediated NDUFA9 upregulation promotes NSCLC cell growth through mitochondrial and Akt-mTOR pathway modulation | PDF",1790095895,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8c117ea89cc17046025b8036d51d3a9.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bad898c68c122fc1bbdfa9e0686bca95.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7ad324bfab83603e482c5bb6702f720.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45afc724dedaeeb11e1e93167e906b7f.webp",980,1301]